Morten Graugaard, Orbis Medicines CEO
January 6, 2025 06:30 AM ESTUpdated 04:02 PM
Financing

Eu­ro­pean macro­cy­cle start­up Or­bis rais­es €90M

Lei Lei Wu

News Reporter

As in­ter­est grows in the abil­i­ty to lever­age cer­tain ringed mol­e­cules as drugs, Or­bis Med­i­cines has raised €90 mil­lion in new fund­ing less than a …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Cal­i­co, De­nal­i's ALS drugs miss pri­ma­ry ob­jec­tives in bas­ket study

Met­sera’s long-act­ing GLP-1 looks com­pet­i­tive in Phase 2 obe­si­ty study

J&J's new can­cer com­bo beats As­traZeneca's Tagris­so on sur­vival in lung tri­al

Ver­tex signs in vi­vo gene edit­ing de­liv­ery pact for sick­le cell and tha­lassemia as it looks be­yond Cas­gevy

FDA sets an ef­fi­ca­cy thresh­old for fu­ture weight loss drugs

Im­muneer­ing touts pos­i­tive pan­cre­at­ic can­cer da­ta for MEK in­hibitor

A service from the Financial Times